CompuGroup Medical SE & Co KgaA
XETRA:COP

Watchlist Manager
CompuGroup Medical SE & Co KgaA Logo
CompuGroup Medical SE & Co KgaA
XETRA:COP
Watchlist
Price: 28.66 EUR 1.85% Market Closed
Updated: May 22, 2024

Net Margin
CompuGroup Medical SE & Co KgaA

4.2%
Current
6%
Average
2%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
4.2%
=
Net Income
50.1m
/
Revenue
1.2B

Net Margin Across Competitors

Country Company Market Cap Net
Margin
DE
CompuGroup Medical SE & Co KgaA
XETRA:COP
1.5B EUR
4%
US
Veeva Systems Inc
NYSE:VEEV
33.7B USD
22%
US
Cerner Corp
NASDAQ:CERN
27.9B USD
10%
US
Change Healthcare Inc
NASDAQ:CHNG
9B USD
-2%
AU
Pro Medicus Ltd
ASX:PME
11.8B AUD
48%
JP
M3 Inc
TSE:2413
1.1T JPY
19%
US
Doximity Inc
NYSE:DOCS
5.3B USD
31%
US
Inspire Medical Systems Inc
NYSE:INSP
4.5B USD
-2%
SE
Sectra AB
STO:SECT B
45.9B SEK
26%
US
Vocera Communications Inc
NYSE:VCRA
2.8B USD
-4%
US
Goodrx Holdings Inc
NASDAQ:GDRX
2.7B USD
-1%
CompuGroup Medical SE & Co KgaA
XETRA:COP
Country DE
Market Cap 1.5B EUR
Net Margin
4%
Veeva Systems Inc
NYSE:VEEV
Country US
Market Cap 33.7B USD
Net Margin
22%
Cerner Corp
NASDAQ:CERN
Country US
Market Cap 27.9B USD
Net Margin
10%
Change Healthcare Inc
NASDAQ:CHNG
Country US
Market Cap 9B USD
Net Margin
-2%
Pro Medicus Ltd
ASX:PME
Country AU
Market Cap 11.8B AUD
Net Margin
48%
M3 Inc
TSE:2413
Country JP
Market Cap 1.1T JPY
Net Margin
19%
Doximity Inc
NYSE:DOCS
Country US
Market Cap 5.3B USD
Net Margin
31%
Inspire Medical Systems Inc
NYSE:INSP
Country US
Market Cap 4.5B USD
Net Margin
-2%
Sectra AB
STO:SECT B
Country SE
Market Cap 45.9B SEK
Net Margin
26%
Vocera Communications Inc
NYSE:VCRA
Country US
Market Cap 2.8B USD
Net Margin
-4%
Goodrx Holdings Inc
NASDAQ:GDRX
Country US
Market Cap 2.7B USD
Net Margin
-1%

Profitability Report

View the profitability report to see the full profitability analysis for CompuGroup Medical SE & Co KgaA.

Full Profitability Report

See Also

Summary
COP intrinsic value, competitors valuation, and company profile.
DCF Valuation
COP stock valuation using Discount Cash Flow valuation method.
Relative Valuation
COP stock valuation using valuation multiples.
Wall Street Estimates
COP price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
COP stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
4.2%
=
Net Income
50.1m
/
Revenue
1.2B
What is the Net Margin of CompuGroup Medical SE & Co KgaA?

Based on CompuGroup Medical SE & Co KgaA's most recent financial statements, the company has Net Margin of 4.2%.

ALPHA SPREAD
Join more than 139,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.